Turkish Pharmaceutical Market (ex-factory prices)
The Turkish pharmaceutical market reached 47,9 billion Turkish Liras (TL) in 2020. During the same period unit sales reached 2,20 billion units.
Source: IQVIA, IEIS
Originator vs. Generic Drugs
Source: IQVIA,IEIS
Source: IQVIA,IEIS
Market Share of Originator vs Generic Drugs
Source: IQVIA,IEIS
Import-Local Products
Source: IQVIA, IEIS
Source: IQVIA, IEIS
Market Share - Import vs. Local
Source: IQVIA, IEIS
Pharmaceutical Consumption by Therapeutic Class
Pharmaceutical Consumption in Value Terms by Therapeutical Class
Oncology represented the largest proportion by value, accounting for 14,5% of the total market.
Source: IQVIA, IEIS
Pharmaceutical Consumption in Volume Terms by Therapeutical Class
Cardiovascular drugs represented the largest proportion by volume, accounting for 10,5% of the total market.
Source: IQVIA, IEIS
Biotechnological Products
Biotechnological products constituted 18,2% of prescription products with 8,7 billion TL and 34,3 million units in 2020. The reference biotechnological pharmaceutical market grew by 22,5% to total 7,8 billion TL. Biosimilar drugs market increased by 48,3% and reached 907,1 million TL.
Source: IQVIA, IEIS
Source: IQVIA, IEIS
Foreign Trade
Pharmaceutical exports reached $1,8 billion in 2020.
Source:TurkStat, IEIS
Source:TurkStat, IEIS